Global Artificial Intelligence (AI) in Genomics Market was valued at US$ 349.58 million in 2021 and it is expected to grow a CAGR of 48.79% during the forecast period of 2022-2030. The Global Artificial Intelligence in Genomics market is segmented on the basis of offering, application, technology type, functionality, and region. Based on the offering, the AI in the genomics market is divided into Software, Services. Based on the application, the AI in the genomics market is divided into Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Other Applications. On the basis of technology, the market is segmented into Machine Learning and Other Technologies. Machine Learning is further segmented into Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other Machine Learning Technologies. The growing research and development activities for the development of advanced treatment to treat various diseases and the high application of machine learning and deep learning in drug development are expected to the market growth significantly in the coming years. By Functionality, the market is segmented into Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine. By end-user, the market is segmented into Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes & Government Organizations, and Other End-Users. The growing adoption of AI in the large number of companies operating in drug development and research activities is expected to propel the growth AI in the genomics market significantly. Based on the region, the market is segmented into Latin America, Asia Pacific, Middle East & Africa, North America, and Europe. In 2019, North America accounted for the largest share in AI in the genomics market, followed by Europe.
The Key Players of this market include AI Therapeutics, Inc., Ares Genetics GmbH, BenevolentAI, BioSymetrics, Cambridge Cancer Genomics (UK), Clover Therapeutics, Congenica Ltd, Coral Genomics, CureMatch, Inc., Cyclica Inc., Data4Cure, Inc, Deep Genomics, Desktop Genetics Ltd., Diploid (Belgium), DNAnexus, Emedgene, Empiric Logic, Engine Biosciences Pte. Ltd., Fabric Genomics, Inc., FDNA Inc. (US), Freenome Holdings, Inc., Genoox, Ltd., IBM (US), LifebitAI, Microsoft (Project Hanover), MolecularMatch Inc. (US), NVIDIA Corporation (US), PrecisionLife Ltd, Predictive Oncology, SOPHiA GENETICS, Inc., Trace Genomics, Verge Genomics, WhiteLab Genomics, WuXi Nextcode Genomics among others. The growing collaboration among hospitals and research institutes, and biopharmaceutical companies is boosting the growth of the adoption of AI on the genomics market globally.